Page last updated: 2024-10-29

isoflurane and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

isoflurane has been researched along with Anti-N-Methyl-D-Aspartate Receptor Encephalitis in 1 studies

Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gumbinger, C1
Hametner, C1
Wildemann, B1
Veltkamp, R1
Bösel, J1

Other Studies

1 other study available for isoflurane and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

ArticleYear
Administration of isoflurane-controlled dyskinetic movements caused by anti-NMDAR encephalitis.
    Neurology, 2013, May-21, Volume: 80, Issue:21

    Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Dyskinesia, Drug-Induced; Female; Humans; Is

2013